Clinical trial
An Observational Study of Patients With Metabolic Syndrome and Related Conditions
NCT05842811 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Patients With Metabolic Syndrome and Related Conditions
- Lead sponsor
- Target PharmaSolutions, Inc.
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 24, 2023
- Completion date
- December 31, 2038
- Enrollment
- 2,000,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.